| Literature DB >> 31531207 |
Micael R Cunha1, Rajesh Bhardwaj2, Sonja Lindinger3, Carmen Butorac3, Christoph Romanin3, Matthias A Hediger2, Jean-Louis Reymond1.
Abstract
Herein we report the first photoswitchable inhibitor of Transient Receptor Potential Vanilloid 6 (TRPV6), a selective calcium channel involved in a number of diseases and in cancer progression. By surveying analogs of a previously reported TRPV6 inhibitor appended with a phenyl-diazo group, we identified a compound switching between a weak TRPV6 inhibitor in its dark, E-diazo stereoisomer (Z/E = 3:97, IC50 ≫ 10 μM) and a potent inhibitor as the Z-diazo stereoisomer accessible reversibly by UV irradiation at λ = 365 nm (Z/E = 3:1, IC50 = 1.7 ± 0.4 μM), thereby allowing precise spatiotemporal control of inhibition. This new tool compound should be useful to deepen our understanding of TRPV6.Entities:
Year: 2019 PMID: 31531207 PMCID: PMC6746075 DOI: 10.1021/acsmedchemlett.9b00298
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345